VERASTEM INC (VSTM:NASDAQ)
$4.1 0.16 (4.0609%)
Analysed VERASTEM INC (VSTM:NASDAQ) News Sources
Verastem (VSTM) Reports Q1 Loss, Misses Revenue Estimates
07-05-2026
yahoo.com
On World Ovarian Cancer Day, LGSOC Resource Guide Launches to Support People Living with Low-Grade Serous Ovarian Cancer
08-05-2026
yahoo.com
Verastem (VSTM) Q1 2026 Earnings Transcript
08-05-2026
fool.com
Verastem Q1 Earnings Call Highlights
09-05-2026
marketbeat.com
Verastem, Inc. (NASDAQ:VSTM) Just Released Its First-Quarter Earnings: Here's What Analysts Think
11-05-2026
yahoo.com
Verastem Oncology to Present at Upcoming Investor Conferences
12-05-2026
yahoo.com
Verastem (VSTM) Loses 34.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
18-05-2026
yahoo.com
Verastem Oncology Appoints Michael P. Bailey to its Board of Directors
26-05-2026
yahoo.com
Verastem Oncology Announces U.S. FDA Fast Track Designation for VS-7375, an Oral and Potential Best-in-Class Investigational KRAS G12D (ON/OFF) Inhibitor for the Treatment of KRAS G12D-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
03-06-2026
yahoo.com
VSTM Stock Climbs After-Hours As FDA Grants Fast Track To Lung Cancer Drug — Retail Eyes The Next Keytruda
04-06-2026
stocktwits.com
What is the current price of VERASTEM INC (VSTM:NASDAQ)?
The current price of VERASTEM INC (VSTM:NASDAQ) is $4.1.
VERASTEM INC (VSTM:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERASTEM INC (VSTM:NASDAQ) since the previous trading day is $0.16.
VERASTEM INC (VSTM:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERASTEM INC (VSTM:NASDAQ) since the previous trading day is 4.0609%.
What is the most recent average sentiment score for VERASTEM INC (VSTM:NASDAQ)?
The most recent average sentiment score for VERASTEM INC (VSTM:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for VERASTEM INC (VSTM:NASDAQ)?
The most recent sentiment for VERASTEM INC (VSTM:NASDAQ) is .
SEC-8K** Filing Available For VERASTEM INC (VSTM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.